Почетна › Ulcerativni kolitis › Тексас
Kliničke studije za Ulcerativni kolitis u državi Тексас
30 studija za Ulcerativni kolitis traži učesnike na lokacijama u državi Тексас.
Gradovi u državi Тексас
- Houston14 студија
- Tyler13 студија
- San Antonio13 студија
- Lubbock9 студија
- Round Rock8 студија
- Lewisville8 студија
- Garland8 студија
- Fort Worth8 студија
- League City7 студија
- Dallas6 студија
- The Woodlands6 студија
- Arlington3 студија
Zvanični tekst studije (na engleskom)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-024, Garland
- Site US-009, Georgetown
- Site US-030, Houston
- и још 4
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07845487Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04751396Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- и још 2
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Texas Digestive Disease Consultants, Cedar Park
- Baylor College of Medicine, Houston
- Tyler Research Institute, LLC, Tyler
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06636656Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- и још 3
Тражи се учесникФаза 3
Сви узрасти · Оба пола · Ажурирано 10. 11. 2026. · NCT06651281LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Fort Worth, Fort Worth
- GI Alliance - Garland, Garland
- Integrity Advanced Therapeutics, Houston
- и још 4
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07415044A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07483073Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Texas Digestive Disease Consultants - Cedar Park, Cedar Park
- GI Alliance - Dallas - Gaston Avenue, Dallas
- GI Alliance - Fort Worth, Fort Worth
- и још 5
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07186101A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
Тражи се учесникФаза 3
Узраст 3 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06663332A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
- GIA Webster, Webster
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07577856A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT04372108Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cedar Park
- Xencor Investigative Site, Denton
- Xencor Investigative Site, Garland
- и још 8
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT06619990A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- и још 7
Тражи се учесникФаза 4
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 10. 2026. · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- GI Alliance -Garland /ID# 284253, Garland
- и још 10
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07697456A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- ACT-Midwest G1, Abilene
- Cook Children's Health Care System-Dodson Specialty Clinics, Fort Worth
- Cook Children's Medical Center, Fort Worth
Тражи се учесникФаза 2
Узраст од 12 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT05287126A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 013, Cedar Park
- Site 005, Garland
- Site 002, San Antonio
- и још 2
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07012395A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Texas - Southwestern Medical Center /ID# 271835, Dallas
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 27. 10. 2026. · NCT07071519An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
- Brooke Army Medical center, San Antonio
- и још 2
Тражи се учесникОпсервациона студија
Узраст од 18 до 64 · Оба пола · Ажурирано 26. 10. 2026. · NCT06398626An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research - Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
- Valley Institute of Research - Site Number: 8400004, Harlingen
- и још 7
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07184996Confirmatory Clinical Study in Active Ulcerative Colitis
- Southern Star Research Institute, San Antonio
Тражи се учесникФаза 2
Узраст 16 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07296315A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0103, Fort Worth
- Texas Children's Hospital, Houston
Тражи се учесникФаза 2/3
Узраст од 2 до 17 · Оба пола · Ажурирано 20. 10. 2026. · NCT05076175A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- One of a Kind Clinical Research Center TX, LLC-Site Number: 8400125, Kingwood
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
- и још 2
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 16. 10. 2026. · NCT07185009A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
Тражи се учесникФаза 3
Узраст од 2 до 19 · Оба пола · Ажурирано 7. 10. 2026. · NCT04844606Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Amarillo Premier Research (Objective Health), Amarillo
- Digestive Research of Central Texas (Objective Health), Waco
Тражи се учесник
Узраст од 18 до 85 · Оба пола · Ажурирано 6. 8. 2026. · NCT06571669A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 22. 5. 2026. · NCT06764615A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
Тражи се учесникФаза 3
Узраст 2 и старији · Оба пола · Ажурирано 7. 5. 2026. · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- и још 5
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 3. 2026. · NCT07113522Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
Тражи се учесникОпсервациона студија
Узраст од 18 до 100 · Оба пола · Ажурирано 18. 5. 2021. · NCT04617184Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.